In your world – numbers and data can save lives. Minutes and seconds absolutely matter. Whether engaged in genome sequencing, drug design, product analysis or risk management, life sciences research teams need high-performance technical environments with the ability to process massive amounts of data and support increasingly sophisticated simulations and analyses.
Global CEO Initiative on Alzheimer’s Disease Announces a Big Data Challenge
November 11, 2013 by
Challenge to be first in a series to crowdsource Alzheimer’s data for new disease insights .
Leveraging High Quality Data to Discover Drugs
November 7, 2013 by
The IP & Science Business of Thomson Reuters has announced a strategic initiative with NuMedii. The companies will leverage high-quality data, knowledge and predictive technologies to identify therapeutic candidates with the greatest probability for clinical success.
